Lifeward
Rehabilitation technology company behind the ReWalk exoskeleton, formerly known as ReWalk Robotics.
Lifeward, previously ReWalk Robotics, sells physical rehabilitation and recovery products including the ReWalk exoskeleton, the AlterG Anti-Gravity System, the ReStore Exo-Suit and the MyoCycle FES system. The company dates back to 2001 and runs operations in the United States, Israel and Germany, with offices in Yokneam Ilit and Marlborough, Massachusetts. In January 2025 it closed a registered direct offering of 1,818,183 shares at $2.75 each, bringing in about $5.0 million gross. A public offering of 4,000,000 shares with matching warrants at $0.65 closed in June 2025 for about $2.6 million gross. In March 2026 Lifeward completed a strategic partnership with Oramed that brought in clinical stage oral protein delivery technology and drew $10 million on closing day from a capital pool that can reach $47 million.
- Latest funding
- $10M
- Total funding
- $17.6M
- Latest valuation
- —
- Founded
- 2001
- Country
- Israel
- Mar 25, 2026Strategic investment$10MLed by Oramed
- Jun 26, 2025Public offering$2.6M
- Jan 8, 2025Registered direct offering$5M